Form 4: Agenus Inc. Executive Jennifer Buell Receives Stock Options as Retention Award

Agenus Inc. executive Jennifer Buell was granted 300,000 stock options as a one-time retention award.

Summary

• Jennifer Buell, a director and officer at Agenus Inc., received 300,000 stock options as a retention award.
• The options were granted on November 14, 2024, with an exercise price of $2.77 per share.
• These options will vest on November 15, 2025, and expire on November 14, 2034.
• The options were awarded under the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan.
• The grant is part of a one-time retention program for key employees, including executive officers.

Sentiment

Score: 7

Explanation: The document reflects a standard practice of executive compensation, which is generally viewed positively as it aligns management and shareholder interests. The sentiment is neutral to positive.

Positives

• The stock option grant serves as a retention incentive for a key executive.
• The vesting period of one year may encourage long-term commitment from the executive.
• The grant aligns the executive's interests with those of the shareholders.

Risks

• The value of the options is dependent on the future performance of Agenus Inc.'s stock price.
• There is a risk that the executive may leave the company before the options vest.

Future Outlook

The stock options will vest on November 15, 2025, contingent on the executive's continued employment.

Management Comments

• The options were awarded in accordance with the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan.

Industry Context

Stock option grants are a common practice in the biotechnology industry to attract and retain key talent.

Comparison to Industry Standards

• Stock option grants are a standard form of compensation for executives in the biotech industry, often used to align management interests with shareholder value.
• The vesting period of one year is relatively standard for such grants, although some companies may use longer or shorter vesting periods.
• The exercise price of $2.77 is specific to Agenus Inc.'s stock price at the time of the grant and would need to be compared to similar grants at comparable companies to assess its relative value.

Stakeholder Impact

• Shareholders may view the stock option grant positively as it incentivizes the executive to improve company performance.
• Employees may see this as a positive sign of the company's commitment to retaining key talent.

Key Dates

Keywords

stock options, retention award, executive compensation, Agenus Inc., equity incentive plan, Jennifer Buell